Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 28 | 2025 | 373 | 6.650 |
Why?
|
| Nucleus Accumbens | 12 | 2023 | 43 | 3.840 |
Why?
|
| Fentanyl | 4 | 2025 | 73 | 2.680 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2025 | 119 | 2.500 |
Why?
|
| Analgesics, Opioid | 10 | 2025 | 492 | 2.330 |
Why?
|
| Sleep | 5 | 2025 | 215 | 2.180 |
Why?
|
| Opioid-Related Disorders | 5 | 2025 | 457 | 2.120 |
Why?
|
| Cocaine | 8 | 2023 | 99 | 1.870 |
Why?
|
| Sex Characteristics | 9 | 2021 | 199 | 1.610 |
Why?
|
| Sleep Wake Disorders | 4 | 2025 | 65 | 1.590 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 688 | 1.300 |
Why?
|
| Ethanol | 9 | 2020 | 309 | 1.240 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 3240 | 1.230 |
Why?
|
| Animals | 45 | 2025 | 19705 | 1.160 |
Why?
|
| Reward | 8 | 2022 | 85 | 1.110 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2025 | 33 | 1.090 |
Why?
|
| Mice | 29 | 2025 | 10316 | 1.070 |
Why?
|
| Corpus Striatum | 4 | 2024 | 93 | 1.060 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 218 | 1.030 |
Why?
|
| Period Circadian Proteins | 3 | 2015 | 71 | 0.970 |
Why?
|
| Motor Activity | 7 | 2015 | 333 | 0.960 |
Why?
|
| Glycerides | 1 | 2024 | 11 | 0.900 |
Why?
|
| Arachidonic Acids | 1 | 2024 | 23 | 0.900 |
Why?
|
| Endocannabinoids | 1 | 2024 | 20 | 0.890 |
Why?
|
| Circadian Clocks | 3 | 2017 | 44 | 0.850 |
Why?
|
| Chronobiology Disorders | 2 | 2014 | 5 | 0.840 |
Why?
|
| Brain | 8 | 2023 | 1495 | 0.830 |
Why?
|
| Prefrontal Cortex | 5 | 2023 | 111 | 0.830 |
Why?
|
| Stress, Psychological | 2 | 2019 | 445 | 0.830 |
Why?
|
| Alcohol Drinking | 6 | 2018 | 291 | 0.800 |
Why?
|
| Hormones | 2 | 2021 | 60 | 0.780 |
Why?
|
| Analgesia | 1 | 2022 | 30 | 0.780 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 139 | 0.750 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2022 | 124 | 0.740 |
Why?
|
| Male | 37 | 2025 | 27952 | 0.720 |
Why?
|
| Valproic Acid | 1 | 2020 | 26 | 0.700 |
Why?
|
| Nerve Tissue Proteins | 6 | 2022 | 418 | 0.670 |
Why?
|
| Sirtuin 1 | 3 | 2022 | 25 | 0.660 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 250 | 0.640 |
Why?
|
| Aggression | 1 | 2019 | 52 | 0.640 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 5 | 0.620 |
Why?
|
| Fibroblasts | 1 | 2021 | 378 | 0.620 |
Why?
|
| Neurons | 5 | 2024 | 865 | 0.620 |
Why?
|
| Transcription Factors | 4 | 2022 | 1473 | 0.610 |
Why?
|
| Depression | 3 | 2024 | 831 | 0.600 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 33 | 0.590 |
Why?
|
| Brain Diseases | 1 | 2019 | 71 | 0.580 |
Why?
|
| Longevity | 1 | 2019 | 110 | 0.570 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 84 | 0.540 |
Why?
|
| Antipsychotic Agents | 4 | 2024 | 296 | 0.540 |
Why?
|
| Dopamine | 3 | 2022 | 102 | 0.520 |
Why?
|
| Anxiety | 3 | 2020 | 388 | 0.500 |
Why?
|
| beta-Endorphin | 2 | 2015 | 8 | 0.500 |
Why?
|
| Female | 23 | 2025 | 30925 | 0.480 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2015 | 20 | 0.470 |
Why?
|
| Schizophrenia | 3 | 2022 | 247 | 0.450 |
Why?
|
| Spleen | 2 | 2013 | 480 | 0.450 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1555 | 0.440 |
Why?
|
| Humans | 30 | 2025 | 59737 | 0.440 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 141 | 0.430 |
Why?
|
| CLOCK Proteins | 4 | 2018 | 46 | 0.420 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 151 | 0.420 |
Why?
|
| Transcriptome | 6 | 2024 | 345 | 0.410 |
Why?
|
| Granzymes | 1 | 2013 | 18 | 0.410 |
Why?
|
| Wakefulness | 2 | 2024 | 42 | 0.410 |
Why?
|
| Perforin | 1 | 2013 | 31 | 0.410 |
Why?
|
| Dopaminergic Neurons | 3 | 2021 | 36 | 0.400 |
Why?
|
| Proteome | 2 | 2023 | 141 | 0.390 |
Why?
|
| Psychotic Disorders | 2 | 2024 | 149 | 0.390 |
Why?
|
| Behavior | 1 | 2012 | 36 | 0.380 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 173 | 0.370 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2060 | 0.370 |
Why?
|
| Rats | 7 | 2021 | 1911 | 0.360 |
Why?
|
| Interferon-gamma | 1 | 2013 | 551 | 0.350 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 34 | 0.340 |
Why?
|
| Immune System | 1 | 2011 | 129 | 0.340 |
Why?
|
| Computational Biology | 1 | 2012 | 334 | 0.330 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 727 | 0.320 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 82 | 0.310 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 55 | 0.290 |
Why?
|
| Biological Clocks | 3 | 2009 | 69 | 0.260 |
Why?
|
| Inflammation | 2 | 2025 | 1101 | 0.260 |
Why?
|
| Animals, Newborn | 2 | 2025 | 230 | 0.250 |
Why?
|
| Glutamic Acid | 3 | 2022 | 95 | 0.250 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 604 | 0.250 |
Why?
|
| Extraembryonic Membranes | 1 | 2025 | 5 | 0.240 |
Why?
|
| Locomotion | 3 | 2021 | 111 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 160 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2018 | 219 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2012 | 724 | 0.230 |
Why?
|
| Central Nervous System Depressants | 4 | 2015 | 42 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 637 | 0.210 |
Why?
|
| Premature Birth | 1 | 2025 | 108 | 0.210 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 113 | 0.210 |
Why?
|
| Ketamine | 1 | 2023 | 32 | 0.210 |
Why?
|
| Morphine | 1 | 2023 | 51 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2024 | 229 | 0.210 |
Why?
|
| Aging | 2 | 2021 | 712 | 0.200 |
Why?
|
| Metformin | 1 | 2024 | 65 | 0.200 |
Why?
|
| Periodicity | 1 | 2023 | 49 | 0.200 |
Why?
|
| Hyperalgesia | 1 | 2022 | 12 | 0.200 |
Why?
|
| Cytokines | 2 | 2021 | 913 | 0.200 |
Why?
|
| Drug Tolerance | 1 | 2022 | 30 | 0.200 |
Why?
|
| Arousal | 1 | 2022 | 41 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 335 | 0.190 |
Why?
|
| NAD | 2 | 2022 | 50 | 0.190 |
Why?
|
| Analgesics | 1 | 2022 | 96 | 0.190 |
Why?
|
| Electroencephalography | 1 | 2022 | 136 | 0.190 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 84 | 0.190 |
Why?
|
| Buprenorphine | 1 | 2025 | 182 | 0.190 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 37 | 0.190 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Hypothalamus | 2 | 2012 | 130 | 0.180 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 2 | 0.180 |
Why?
|
| Eye Movements | 1 | 2022 | 82 | 0.180 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 14 | 0.180 |
Why?
|
| Astrocytes | 1 | 2022 | 116 | 0.180 |
Why?
|
| Glucagon | 1 | 2021 | 33 | 0.180 |
Why?
|
| Genetics | 1 | 2021 | 13 | 0.180 |
Why?
|
| Models, Biological | 4 | 2017 | 1146 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 30 | 0.180 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 70 | 0.180 |
Why?
|
| Mutation | 3 | 2020 | 2462 | 0.180 |
Why?
|
| Neurosciences | 1 | 2021 | 26 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 34 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2023 | 393 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 367 | 0.170 |
Why?
|
| Species Specificity | 3 | 2020 | 329 | 0.170 |
Why?
|
| Insulin | 3 | 2023 | 672 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2021 | 66 | 0.170 |
Why?
|
| Drinking | 2 | 2018 | 14 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2012 | 590 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 534 | 0.170 |
Why?
|
| Software | 1 | 2023 | 366 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 398 | 0.160 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 163 | 0.160 |
Why?
|
| Social Behavior | 1 | 2019 | 88 | 0.150 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 27 | 0.150 |
Why?
|
| Clozapine | 1 | 2018 | 32 | 0.150 |
Why?
|
| Genotype | 1 | 2020 | 621 | 0.140 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 16 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 143 | 0.140 |
Why?
|
| Synapses | 1 | 2019 | 179 | 0.140 |
Why?
|
| Lithium | 1 | 2017 | 14 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 304 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 870 | 0.130 |
Why?
|
| Norepinephrine | 2 | 2021 | 98 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2016 | 69 | 0.130 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 680 | 0.130 |
Why?
|
| Fasting | 1 | 2015 | 48 | 0.120 |
Why?
|
| Self Administration | 3 | 2020 | 48 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 25 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 259 | 0.120 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 147 | 0.120 |
Why?
|
| Lithium Chloride | 1 | 2015 | 1 | 0.120 |
Why?
|
| Corticosterone | 1 | 2015 | 22 | 0.120 |
Why?
|
| Antimanic Agents | 1 | 2015 | 27 | 0.120 |
Why?
|
| Body Temperature | 1 | 2015 | 45 | 0.120 |
Why?
|
| Running | 1 | 2015 | 80 | 0.120 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 149 | 0.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.120 |
Why?
|
| Maze Learning | 1 | 2015 | 50 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 34 | 0.120 |
Why?
|
| Restraint, Physical | 1 | 2015 | 34 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 180 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 170 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 243 | 0.110 |
Why?
|
| Amygdala | 1 | 2015 | 79 | 0.110 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adolescent | 3 | 2024 | 5866 | 0.110 |
Why?
|
| Pregnancy | 2 | 2025 | 2226 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2015 | 461 | 0.100 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 25 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 298 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 52 | 0.100 |
Why?
|
| Photoperiod | 1 | 2012 | 40 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 844 | 0.090 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 34 | 0.090 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 26 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 193 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 145 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 284 | 0.090 |
Why?
|
| Sympathectomy, Chemical | 1 | 2010 | 1 | 0.090 |
Why?
|
| Guanethidine | 1 | 2010 | 2 | 0.090 |
Why?
|
| Sympatholytics | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 153 | 0.080 |
Why?
|
| Time Factors | 3 | 2015 | 3629 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 577 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 620 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 21 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2095 | 0.070 |
Why?
|
| RNA | 1 | 2010 | 405 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1207 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1061 | 0.060 |
Why?
|
| Cosmetics | 1 | 2005 | 17 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 25 | 0.060 |
Why?
|
| Alcoholism | 2 | 2024 | 310 | 0.060 |
Why?
|
| Seizures | 1 | 2005 | 115 | 0.060 |
Why?
|
| Suicide, Attempted | 1 | 2024 | 105 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 309 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 339 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 64 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 250 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 63 | 0.050 |
Why?
|
| Brain Stem | 1 | 2021 | 28 | 0.050 |
Why?
|
| Hippocampus | 1 | 2023 | 251 | 0.050 |
Why?
|
| Rotenone | 1 | 2021 | 10 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 106 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2025 | 325 | 0.040 |
Why?
|
| Insecticides | 1 | 2021 | 30 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 15 | 0.040 |
Why?
|
| Glucose | 1 | 2024 | 444 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 63 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2020 | 25 | 0.040 |
Why?
|
| Rodentia | 1 | 2020 | 22 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 146 | 0.040 |
Why?
|
| Anhedonia | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 5 | 0.040 |
Why?
|
| Light | 2 | 2015 | 198 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 93 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 60 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 288 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 560 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 72 | 0.040 |
Why?
|
| Affect | 1 | 2020 | 123 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 15771 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 38 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Drosophila | 1 | 2021 | 422 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 102 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2018 | 118 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 211 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2390 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 79 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1289 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2017 | 76 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 749 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 152 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 38 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 266 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 811 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2000 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 225 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 557 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2387 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 440 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 981 | 0.030 |
Why?
|
| alpha-MSH | 1 | 2012 | 3 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 7 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 30 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 809 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 69 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7448 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 16449 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1511 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 592 | 0.020 |
Why?
|
| Triazolam | 1 | 2007 | 4 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 93 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 155 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 62 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2007 | 89 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 366 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5147 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4290 | 0.020 |
Why?
|
| Camphor | 1 | 2005 | 1 | 0.020 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 2 | 0.010 |
Why?
|
| Activity Cycles | 1 | 2005 | 3 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2005 | 159 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1496 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 13510 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1802 | 0.010 |
Why?
|